Latest period
$0.00
YoY change
—
5Y CAGR
—
Peak year (2017)
$2.94M
Latest annual
$0.00
Total Debt history chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: $0.00
Total Debt growth chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: -100.0%
Total Debt history table for Relmada Therapeutics (RLMD) from 2012 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | — | $0.00 | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | -100.0% | −$110.25K | ||
| 2019 | $110.25K | -69.7% | −$253.96K | ||
| 2018 | $364.20K | -87.6% | −$2.58M | ||
| 2017 | $2.94M | +963.2% | +$2.66M | ||
| 2016 | $276.67K | +1.1% | +$3.00K | ||
| 2015 | $273.67K | +3.8% | +$9.92K | ||
| 2014 | $263.75K | +352.0% | +$205.40K | ||
| 2013 | $58.36K | — | +$58.36K | ||
| 2012 | $0.00 | — | — |
- 2025$0.00—
- 2024$0.00—
- 2023$0.00—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00-100.0%
- 2019$110.25K-69.7%
- 2018$364.20K-87.6%
- 2017$2.94M+963.2%
- 2016$276.67K+1.1%
- 2015$273.67K+3.8%
- 2014$263.75K+352.0%
- 2013$58.36K—
- 2012$0.00—
Total Debt values are taken from Relmada Therapeutics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Relmada Therapeutics (RLMD)
According to Relmada Therapeutics's latest reported financial statements, the company's latest reported total debt is $0.00. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Relmada Therapeutics (RLMD) total debt totalled $0.00.
Relmada Therapeutics total debt compound annual growth for the 2015–2025 (10 years) window is -100.0%, with a net decline across the window.
2017 marks the peak total debt at $2.94M, with the historical low of $0.00 recorded in 2012.
Relmada Therapeutics Total Debt by Year
Relmada Therapeutics Total Debt 2025: $0.00
Relmada Therapeutics total debt in 2025 was $0.00.
Relmada Therapeutics Total Debt 2024: $0.00
Relmada Therapeutics total debt in 2024 was $0.00.
Relmada Therapeutics Total Debt 2023: $0.00
Relmada Therapeutics total debt in 2023 was $0.00.
Relmada Therapeutics Total Debt 2022: $0.00
Relmada Therapeutics total debt in 2022 was $0.00.
Relmada Therapeutics Total Debt 2021: $0.00
Relmada Therapeutics total debt in 2021 was $0.00.
See more financial history for Relmada Therapeutics (RLMD).
Sector peers by Total Debt
Healthcare peers of Relmada Therapeutics (RLMD), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation